Medable Inc., a provider of digitally-enabled and data-driven clinical trials, will join the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network. The Center is focused on building health-tech relationships to drive innovative and scalable solutions across the health continuum.American Heart Association’s Center for Health Technology & Innovation Innovators NetworkThe Center helps members of its Innovators Network in the healthcare
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
MedAnswers Raises $5M for Scientifically, Clinically Validated FertilityAnswers App
MedAnswers, a health tech company has raised $5 million in seed round funding led by Special Situations’ Life Sciences Innovation (LSI) Fund, managed by David Sable, with Viking Global Investors also participating. MedAnswers is leveraging technology, genetics and other health data to match those struggling to conceive to a curated network of fertility experts and solutions to help users conceive faster. The company is a graduate of the 7th cycle of Illumina Accelerator. FertilityAnswers AppThe
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
What Is The Upside of Establishing Extended Reality As A Medical Device?
XR stands for extended reality. Basically, it's an umbrella term covering the VR (virtual reality), AR (augmented reality), and MR (mixed reality) technologies. All three are already involved or will be involved in healthcare. In the very near future, you will be able to “swipe” between all three within an application. Different combinations of the technologies will be used to provide specific health benefits, eventually all within a single platform.
It is sometimes hard to explain to people
Read More
Stanford, Sutter Health to Explore Joint Cancer Care Services in East Bay
Stanford Health Care and Sutter Health have signed a letter of intent to explore opportunities to jointly provide cancer care for patients and their families in the East Bay region of the San Francisco/Oakland metropolitan area. The intent of the collaboration is to increase access to high-quality cancer care for patients as close to home as possible by building on the strength of Stanford’s leadership in cancer care and clinical research, the Stanford Medicine network and Sutter’s integrated
Read More
Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data
Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis' mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.Impact of Heart FailureHeart failure afflicts approximately 6.5 million patients in the United States and
Read More
Notable Nabs $40M to Expand Drug Discovery Platform for Personalized Oncology
Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development has raised $40M in Series B funding. The Series B round is co-led by B Capital Group and LifeForce Capital. LifeForce is a returning investor, joined by new investors B Capital and Industry Ventures. This latest round brings Notable’s total funding to over $55M.Notable was founded in 2017 by Matt De Silva after helping his own father Marc, who
Read More
Procyrion Raises $30M to Support Clinical Trials of its Percutaneous Blood Pump Device
Procyrion, Inc., a Houston-based medical device firm developing the first catheter-deployed, intra-aortic pump initially for use in cardiorenal syndrome patients announced it has raised $30 million in Series D funding led by Bluebird Ventures. The round also includes participation from existing investors Fannin Partners, Scientific Health Development, the State of Texas, and an undisclosed strategic investor.The company is developing its AortixTM system, a percutaneous blood pump initially
Read More
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights.
What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a similar long-term objective—capturing critical data to improve outcomes.
“People want to
Read More
Cedars-Sinai Accelerator Reveals 5th Class of 11 Digital Health Startups
Cedars-Sinai Accelerator, today announced 11 new digital health startups selected to participate in its fifth class from across the United States and Europe. From artificial intelligence to a smart brace for knee replacement patients, these innovative healthcare-focused startups are working to transform health and healthcare delivery as part of the Los Angeles-based accelerator program. Through their innovations, the companies seek to address some of healthcare’s most pressing challenges,
Read More
